BioNTech settles with NIH, Penn over COVID vaccine royalties
3 days ago · BioNTech will pay the NIH $791.5 million, according to a securities filing (PDF). Of the sum, $750 million stems from claimed royalties on the vaccine from 2020 to 2023, while the remaining $41.5 ...
BioNTech enters settlement with US agency, UPenn over COVID …
Dec 27, 2024 · BioNTech said partner Pfizer will reimburse it for up to $170 million of the royalties payable to Penn and $364.5 million of the royalties paid to the National Institutes of Health (NIH)for 2020 ...
BioNTech Enters Into Settlements With NIH, UPenn Over COVID …
Dec 30, 2024 · BioNTech Enters Into Settlements With NIH, UPenn Over COVID-19 Vaccine Royalties December 30, 2024 Reuters (12/27, Satija, S K) reported, “BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its COVID-19 vaccine ...
BioNTech to Pay Up to $1.26B in Covid-19 Vaccine ... - MarketWatch
Dec 27, 2024 · BioNTech has agreed to pay $1.26 billion across two separate settlements with the National Institutes of Health and the University of Pennsylvania tied to royalties for its Covid-19 vaccine.
BioNTech settles with U.S. agency, University of Pennsylvania over ...
Dec 27, 2024 · BioNTech reached settlements with the U.S. National Institutes of Health and the University of Pennyslvania over royalties related to its Covid-19 vaccine.
BioNTech Enters Into Settlements With U.S. Agency ... - Markets …
Dec 27, 2024 · (RTTNews) - BioNTech SE (BNTX), Friday reached two separate settlements with the U.S. National Institutes of Health, and the University of Pennsylvania regarding the royalties payment of COVID-19 ...
BioNTech to pay $791.5M in settlement agreement with the NIH
Dec 27, 2024 · In a regulatory filing, BioNTech (BNTX) said, “BioNTech previously disclosed that it was in discussions with the National Institutes of Health concerning royalties and other related amounts ...
Newsroom - BioNTech
Videos, photos, press releases or data sheets Learn more about BioNTech!
Press Releases - BioNTech
Sep 20, 2024 · BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update. BioNTech to Host Innovation Series R&D Day on November 14, 2024. BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024. BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day.
BioNTech to Acquire Biotheus to Boost Oncology Strategy
Nov 13, 2024 · With the acquisition, BioNTech will obtain full global rights to the late-stage clinical asset BNT327/PM8002, an investigational bispecific antibody targeting PD-L1 and VEGF-A.